GoodRx Holdings (GDRX) Non-Current Debt (2019 - 2026)

GoodRx Holdings' Non-Current Debt history runs 8 years deep, the most recent figure standing at $482.4 million for Q1 2026.

• In Q1 2026, Non-Current Debt fell 0.7% year-over-year to $482.4 million; the TTM figure through Mar 2026 stood at $482.4 million (down 0.7% YoY), while the FY2025 annual figure was $483.3 million, down 0.71% from the prior year.
• Non-Current Debt came in at $482.4 million for Q1 2026 at GoodRx Holdings, roughly flat from $483.3 million in the prior quarter.
• In the past five years, Non-Current Debt ranged from a high of $654.8 million in Q1 2022 to a low of $482.4 million in Q1 2026.
• A 5-year average of $582.2 million and a median of $646.7 million in 2024 frame the typical range for Non-Current Debt.
• Across the five-year window, Non-Current Debt slipped 0.61% in 2022 and retreated 24.89% in 2025, its largest moves.
• GoodRx Holdings' Non-Current Debt stood at $651.8 million in 2022, then decreased by 0.63% to $647.7 million in 2023, then decreased by 24.86% to $486.7 million in 2024, then dropped by 0.71% to $483.3 million in 2025, then retreated by 0.17% to $482.4 million in 2026.
• According to Business Quant data, Non-Current Debt over the past three periods registered $482.4 million, $483.3 million, and $484.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison